Skip to main content
. 2022 Oct 5;13:1013432. doi: 10.3389/fphar.2022.1013432

TABLE 1.

Parameters required for PBPK model establishment.

Parameter type Value Source
Species information
Individual
Species Human
Race East Asian
Gender Male
Endothelal Surface areas Organ Vasculrization PK-Sim standard
Body surface area Mosteller PK-Sim standard
Age (years) 25.7 Project mean
Weight (kg) 60.98 Project mean
Height (cm) 167.60 Project mean
BMI 21.71 Project mean
Population
Age (years) 18–60 Simulation setting
Number of individuals 100 Simulation setting
Proportion of females 50% Simulation setting
Drug information
Physiochemical properties
log P 0.4 (Drugbank) Optimized value: 0.43
0.421 (ADMETlab) PK-Sim optimization
0.935 (ADMETlab 2.0)
1.38 (SwissADME)
1.57 (ADMESAR)
fu (plasma) 18% (Drugbank) Drugbank
28.64% (ADMETlab 2.0)
33.306% (ADMETlab)
Moleculr weight 170.23 Drugbank
pka (Strongest Acidic) 8.09 Drugbank
pka (Strongest Basic) -2.9 Drugbank
Solublity (mg/L) 1,200 (Drugbank) Drugbank
1,531.278 (ADMETlab)
234 (SwissADME)
Absorption
Specific intestinal permeability (cm/min) 3.92x10−6 Thelen et al. (2011)
Distribution
Specific organ permeability (cm/min) 3.18x10−3 Willmann et al. (2005)
Metabolism and Elimination
Total clearance (L/h) 4.42–13.5 Pan et al. (2001); Tang. et al. (2002); Mendes et al. (2014); Główka et al. (2018)
Optimized value: 9
PK-Sim optimization
Total clearance (L/h/kg) 0.07–0.22
Total hepatic clearance (L/h/kg) 0.09 PK-Sim optimization
Hepatic specific clearance (1/min) 0.36 PK-Sim calculation
Renal clearances (L/h/kg) 0.05 PK-Sim optimization
Renal specific clearance (1/min) 0.70 PK-Sim calculation
Dosing Information
Administration type Oral
Dose (mg) 50
Dosing interval Single
Formulations Dissolved PK-Sim standard